Description
Jason T. Jacobson, MD, FHRS of Westchester Medical Center – New York Medical College and co-host Danesh Kella, MBBS, FHRS of the Mayo Clinic Jacksonville as they discuss the article Epicardial Roof-Dependent Macro-Reentrant Tachycardia After Ablation of Atrial Fibrillation: Prevalence, Electrophysiological Characteristics, and Ablation Strategy. They are joined by guests Pierre Jais, MD of the Université of Bordeaux, CHU Bordeaux, IHU LIRYC and Apoor Patel, MD of Houston Methodist Hospital. This episode was recorded in front of a live audience at Heart Rhythm 2023 in New Orleans, Lousiana.
Learning Objectives
- Define epicardial conduction.
- Determine the best way to map in the context of this topic.
- Determine how and where to ablate in this context.
Target Audience
Electrophysiologists
Allied Professionals
Teaching Hospitals
Fellows
Article Authors and Podcast Contributors
Article Authors
Yiwei Lai, MD, Xueyuan Guo, MD, Caihua Sang, MD, Qi Guo, MD, Mingyang Gao, MD, Lihong Huang, MD, Song Zuo, MD, Xu Li, MD, Chenxi Jiang, MD, Songnan Li, MD, Changyi Li, MD, Nian Liu, MD, Xiaoxia Liu, MD, Xin Zhao, MD, Wei Wang, MD, Ribo Tang, MD, Deyong Long, MD, Xin Du, MD, Jianzeng Dong, MD, Changsheng Ma, MD
Podcast Contributors
Jason T. Jacobson, MD, FHRS of Westchester Medical Center – New York Medical College
Pierre Jais, MD of the Université of Bordeaux, CHU Bordeaux, IHU LIRYC
Danesh Kella, MBBS, FHRS ofr the Mayo Clinic Jacksonville
Apoor Patel, MD of Houston Methodist Hospital
Disclosure Policy
ACE Disclosure Policy
The Heart Rhythm Society is committed to the provision of Accredited Continuing Education (formerly known as Continuing Medical Education (CME)) that is balanced, objective, and evidence based. HRS adheres to the Standards for Integrity and Independence in Accredited Continuing Education of the Accreditation Council for Continuing Medical Education (ACCME) which require that those individuals in a position to control the content of an educational activity (including, but not limited to, planners, faculty, authors, committee members, content reviewers, editors, and staff) disclose all financial relationships with an ACCME-defined ineligible company* within the 24 months prior to the disclosure.
Any individual who refuses to disclose financial relationships is disqualified from participating in HRS ACE-certified activities. Owners and employees of ACCME-defined ineligible companies may have no role in the planning or implementation of ACE activities without a special written exemption from the HRS Chief Learning Officer that will be granted only in specific circumstances that meet ACCME requirements.
ACCME Definition:
*An ineligible company is one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Examples of such organizations include:
- Advertising, marketing, or communication firms whose clients are ineligible companies
- Bio-medical startups that have begun a governmental regulatory approval process
- Compounding pharmacies that manufacture proprietary compounds
- Device manufacturers or distributors
- Diagnostic labs that sell proprietary products
- Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
- Manufacturers of health-related wearable products
- Pharmaceutical companies or distributors
- Pharmacy benefit managers
- Reagent manufacturers or sellers
All relevant financial relationships have been mitigated.Host Disclosure(s):
J. Jacobson: Honraria/Speaking/Consulting Fee: American College of Cardiology, Zoll Medical Corporation; Research (Contracted Grants for PIs Named Investigators Only): Abbott, Phillips; Stock Ownership: Atlas 5D
D. Kella: No relevant financial relationships with ineligible companies to disclose.
Contributor Disclosure(s):
P. Jais: Stock Ownership (Privately Held): Farapulse
A. Patel: Honraria/Speaking/Consulting Fee: Biosense Webster, Boston Scientific
Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner):
J. Glenn: No relevant financial relationships with ineligible companies to disclose.
S. Sailor: No relevant financial relationships with ineligible companies to disclose.